-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Deferred Income Tax Assets, Net history and growth rate from Q1 2023 to Q1 2024.
- LakeShore Biopharma Co., Ltd. Deferred Income Tax Assets, Net for the quarter ending March 31, 2024 was $3.33M, a 1101% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)